DOCSLIB.ORG

The Robert Koch Institute: an Historical Overview

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Robert Koch Institute: an Historical Overview The Robert Koch Institute: one of the world’s oldest Robert Koch’s legacy: biomedical institutes museum and mausoleum Staff members, 1920 1947 New laboratory building, 1980 BSL-4 laboratory Health monitoring Robert Koch’s scientific legacy, which includes 1,100 letters, certificates, manuscripts and notes, microscope slides, lab equipment, numerous After the National Socialist takeover, Jewish The Federal Health Office is dissolved. scientists are forced to leave the institute. photos and Koch’s scientific library, is preserved RKI merges with the AIDS Centre, which The strategy “RKI 2025” envisages During the Third Reich, RKI is heavily in- at the Robert Koch Institute. had been founded in 1988, and the Institute The Bundestag decides to develop extending digital epidemiology, con- volved in National Socialist strong-arm The institute starts producing the for Social Medicine and Epidemiology in RKI into a modern public health necting public health stakeholders Robert Koch is tactics. RKI’s role under National Socialism only yellow fever vaccine licensed by Berlin-Tempelhof—the latter specialising The institute acquires an additional institute (‘RKI 2010’). Staffing and taking on greater responsibility awarded the Nobel has been deeply investigated in a research the WHO in Germany. Production in non-communicable diseases. site in Berlin-Wedding: Seestrasse. numbers are increased. at international level. Prize in Medicine. project. continues until 2002. Robert Koch Protection against Infection Act (Infektions­­­ schutzgesetz, IfSG) enters into force. The A new office and laboratory build- On 1 July, the “Royal Prussian Institute for Parts of the institute have been When the first cases of AIDS registering and control of infectious diseases Together with the Federal Statistical ing is inaugurated at the Seestrasse Infectious Diseases” takes up its work. destroyed during the war. With the occur in Germany, RKI establishes are fundamentally modernised, RKI’s respon- Office, RKI is tasked with health site, including a laboratory with the Robert Koch heads the institute until 1904. help of the Allies, work is resumed. an AIDS register. sibilities are extended. highest safety level (BSL-4). reporting for Germany. 1891 1905 1933 1945 1960 1982 1994 2001 2002 2006 2008 2015 2017 Museum at RKI THE ROBERT KOCH INSTITUTE 1910 1978 1942 2014 1900 1998 2016 2019 1952 1990 2001 2007 2003 Some items can be seen in RKI’s Museum at the Relocation to a new building on The institute becomes an independ- A new laboratory building is RKI conducts its first comprehensive RKI introduces the KiGGS Study: for the In West Africa, 50 members of RKI’s RKI gets its own Centre An Historical Overview the Nordufer in Berlin-Wedding, ent Reich institute called the Robert inaugurated on the Nordufer, one study on the state of health and health first time, comprehensive data on the staff help to contain the largest Ebola for International Health Nordufer site—such as an incubator, scientific still RKI headquarters to this day. Koch Institute. It now focuses on re- of the most modern in Europe. behaviour of adults in Germany. health situation of children and young Virus Disease outbreak in history. Protection. drawings and a steamer in which culture media search into infectious diseases that people are collected nationwide. were sterilised by jets of steam up to 120° Celsius. threaten military striking power. Re-designed in 2017, the exhibition showcases After German reunification, various GDR RKI is officially charged with health moni- The institute celebrates its 125th anniversary. how the institute investigates risks and protection authorities are integrated in RKI, including RKI becomes the central point in Germany toring. The institute thus continuously More than 1,100 people with 90 different factors for the health of the population in the 21st Robert Koch dies and is laid to rest in RKI becomes part of the newly- parts of the Institute for Experimental Epide- for recognising and addressing bioterrorist collects data on disease incidence and risk occupations are employed at the four sites in a mausoleum at the institute. founded Federal Health Office. miology in Wernigerode in the Harz region. risk situations. behaviour amongst all age groups of the Berlin and Wernigerode, including 450 scien- century as well as the importance and current The Wernigerode site is still a branch of RKI. population in Germany. tists. relevance of the discoveries made by Robert Koch and his students. The mausoleum in which Robert Koch’s ashes were laid to rest can also be visited. Ω More on the institute’s history: www.rki.de/history Ω From Robert Koch to Lothar H. Wieler—the Presidents Ω Opening hours and guided tours: of RKI: www.rki.de/presidents www.rki.de/museum-en Robert Koch Institute 2019 | Images: RKI except Hotel Zoo Berlin (Peter Kuley, CC BY-SA 4.0) Institute 2019 | Images: RKI except Hotel Zoo Berlin (Peter Kuley, Robert Koch Producing vaccine against Microbial strain collection, Nordufer, 1900 spotted fever, 1940s Yellow fever laboratory, 1960 Wernigerode HIV Seestraße Robert Koch: In Koch’s footsteps Robert Koch’s A life for research in Berlin students In the 19th century, diseases like tuberculosis, In summer 1880, Robert Koch, his wife Emmy and Emil von Behring, immunologist and serologist. Shibasaburo Kitasato, bacteriologist. Investigat- diphtheria, wound infections and cholera were their daughter Gertrud moved into their first home Developed antisera against diphtheria and teta- ed tetanus and diphtheria, demonstrated the the most common cause of death worldwide. In in Chausseestraße 118 1 in Berlin-Mitte. At the nus; founded the Behring-Werke in Marburg. efficacy of antisera. Founder of today’s Kitasato Germany alone, hundreds of thousands of people Kimberley/South Africa, 1896 Koch and Kitasato in Japan, 1908 time, it was an industrial area, but only a short walk Nobel Prize in Medicine, 1901. Institute in Tokyo. died of them every year. This was the time when from Koch’s workplace, the Kaiserliche Gesund- the doctor, Robert Koch, discovered that diseases which he was awarded the Nobel Prize in Medi- In the course of his career, Robert Koch investi- heitsamt (Imperial Health Authority) in Luisen- Paul Ehrlich, doctor and researcher. Founder of Friedrich Loeffler, physician. Discovered the of this kind were caused by tiny organisms—bac- cine in 1905. All this was thanks to new scientific gated and fought infectious diseases worldwide, straße 57 2 . It was here that he discovered the chemotherapy; developed drugs against syphilis glanders and diphtheria pathogens, investigated teria. He and his colleagues in Berlin managed to methods, such as systematic animal experiments, including malaria in Italy and New Guinea, plague tuberculosis pathogen in 1882. Today, the building and an antiserum against diphtheria. Nobel Prize foot and mouth disease. Co-founder of virology identify many pathogens and infection paths and the cultivation of micro-organisms on solid cul- in India, rinderpest and East Coast fever in South houses, amongst others, the Institute of Sexology in Medicine, 1908. The Paul-Ehrlich-Institut, the and founder of today’s Friedrich Loeffler Insti- 8 thus pave the way for therapies and preventive ture media, microphotography and dyeing tech- Africa—and cholera in Egypt and India. In the and Sexual Medicine that is part of Berlin’s Charité. Federal Institute for Vaccines and Biomedicines, tute for Animal Health on Riems Island. measures. Together with Louis Pasteur, Robert niques, which made it possible not only to trace 19th century, the “Asiatic hydra” had repeatedly was named after him. Koch is now thought of as the pioneer of micro- the pathogens but also to visualise them. Scien- broken out in Germany, too, especially in the big On 24 March 1882, Koch held his lecture on the Bernhard Nocht, harbour physician and tropical biology. tists from all over the world travelled to Berlin to city slums. “Aetiology of Tuberculosis”, which gained him Paul Frosch, bacteriologist and co-founder of medicine specialist. Founder of today’s Bernhard learn about “Koch’s methods”. In 1891, Koch was world fame, at the Physiological Society of Berlin virology. Isolated the foot and mouth disease Nocht Institute for Tropical Medicine. Helped to » Only when it was known what the given his own research institute, the Royal Prus- » I consider it my duty to go and work where in Dorotheenstraße 96 3 . This is now the Robert pathogen and fought malaria, plague, typhus. contain the cholera epidemic in Hamburg in 1892. pathogens themselves were, was it sian Institute for Infectious Diseases, in Berlin- I can be of greatest use to science.« Koch Forum that belongs to the Berlin universi- possible to fight them directly.« Wedding. But he did not manage to fulfil his pri- ties and Charité. Georg Gaffky, bacteriologist and hygienist. Culti- Lydia Rabinowitsch-Kempner, microbiologist. mary objective of finding a remedy for or vaccine In 1892, Robert Koch helped to contain a serious vated, amongst others, typhus pathogens in pure Demonstrated, amongst other things, that As a young doctor in 1876, Robert Koch managed against tuberculosis: “tuberculin”, the drug he cholera outbreak in Hamburg—not least because In April 1885, Koch became the first professor in cultures. As a close colleague of Robert Koch, he tubercle bacteria are transmitted in cow’s milk. for the first time to prove that micro-organisms developed, was a failure. he insisted drinking water should be boiled. In the new Hygiene Institute at Friedrich-Wilhelms- contributed to Koch’s discoveries. First woman in Berlin to hold the title of professor. caused infectious diseases—the test object was 1906/1907, Koch and colleagues travelled to Ger- Universität in Klosterstraße 36 4 . Here he devel- 1890 the anthrax pathogen. In 1878, he discovered the man East Africa to investigate sleeping sickness. oped the ineffective remedy, tuberculin. From 1882 bacteria that lead to wound infections.
Load more

Recommended publications
  • The Rat from an Aircraft: Investigations for Multiple Pathogen Detection
    Poster Presentations New and Re-Emerging Zoonotic Diseases N19 The rat from an aircraft: Investigations for multiple pathogen detection Elisa Heusera, Arnt Ebingerb, Silva Holtfreterc, Andreas Zautnerd, René Rylla, Stephan Drewesa, Beate Matzkeita, Bernd Hoffmannb, Dirk Höperb, Markus Kellera, Allison Grosethf, Gottfried Wilharme, Daniel Mrochenc, Anna Obiegalag, Frank Dossh, Tobias Eisenbergi, Sandra Niendorfj, Sindy Böttcherk, Michael H. Kohnl, Charlotte Schröderm, Joachim Reetzn, Kati Franzkeo, Eric Ehrke-Schulzp, Martin Pfefferg, Katja Schmidtq, Martin Beerb, Rainer G. Ulricha,r,* a Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Institute of Novel and Emerging Infectious Diseases, Südufer 10, 17493 Greifswald-Insel Riems, Germany b Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Institute of Diagnostic Virology, Südufer 10, 17493 Greifswald-Insel Riems, Germany c Department of Immunology, University Medicine Greifswald, 17475 Greifswald, Germany d Institute of Medical Microbiology, University Medicine Göttingen, Kreuzbergring 57, 37075 Göttingen, Germany e Robert Koch Institute, Wernigerode Branch, Burgstr. 37, 38855 Wernigerode, Germany Friedrich-Loeffler- f Institut, Federal Research Institute for Animal Health, Group – Arenavirus Biology, Südufer 10, 17493 Greifswald-Insel Riems, Germany g Institute of Animal Hygiene and Veterinary Public Health, University of Leipzig, An den Tierkliniken 1, 04103 Leipzig, Germany h Clean Frank Doss GmbH, Kampstraße 27, 16792 Zehdenick, Germany i Hessian State Laborytory, Schubertstraße 60 - Haus 13, 35392 Gießen, Germany j Robert Koch-Institute, Department of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Seestraße 10, 13353 Berlin, Germany k Robert Koch-Institute, Regional Reference Laboratory of the WHO/Europe for Poliomyelitis, Seestraße 10, 13353 Berlin, Germany l Rice University, BioSciences, Houston, TX BioSciences MS-170, Rice University, 130 Anderson Biology, P.O.
    [Show full text]
  • October 24–26, 2021 2
    SCIENCE · INNOVATION · POLICIES WORLD HEALTH SUMMIT BERLIN, GERMANY & DIGITAL OCTOBER 24–26, 2021 2 “No-one is safe from COVID-19; “All countries have signed up to Universal no-one is safe until we are all Health Coverage by 2030. But we cannot safe from it. Even those who wait ten years. We need health systems conquer the virus within their that work, before we face an outbreak own borders remain prisoners of something more contagious than within these borders until it is COVID-19; more deadly; or both.” conquered everywhere.” ANTÓNIO GUTERRES Secretary-General, United Nations FRANK-WALTER STEINMEIER Federal President, Germany “We firmly believe that the “All pulling together—this must rights of women and girls be the hallmark of the European are not negotiable.” Health Union. I believe this can NATALIA KANEM be a test case for true global Executive Director, United Nations Population Fund (UNFPA) health compact. The need for leadership is clear and I believe the European Union must as- sume this responsibility.” “The lesson is clear: a strong health URSULA VON DER LEYEN system is a resilient health system. Health President, European Commission systems and preparedness are not only “Governments of countries an investment in the future, they are the that are doing well during foundation of our response today.” the pandemic have not TEDROS ADHANOM GHEBREYESUS Director-General, World Health Organization (WHO) only shown political leader- ship, but also have listened “If we don’t address the concerns and to scientists and followed fears we will not do ourselves a favor. their recommendations.” In the end, it is about how technology SOUMYA SWAMINATHAN Chief Scientist, World Health can be advanced as well as how Organization (WHO) we can make healthcare more human.” BERND MONTAG President and CEO, Siemens Healthineers AG, Germany “The pandemic has brought to light the “Academic collabo ration is importance of digital technologies and in place and is really a how it can radically bridging partnership.
    [Show full text]
  • Annual Status Update on Measles and Rubella Elimination Germany
    Annual Status Update on Measles and Rubella Elimination Germany 1 Dear NVC and national technical counterparts, dear colleagues, We kindly ask you to follow the definitions (please see Annex 1.1) and instructions provided in this form, and to enter numbers or text as required in each segment (table, text box, other). If you are using your own definitions and indicators, please provide an explanation and clarification why and how these could be considered equivalent to or as an adequate replacement for the WHO definitions and indicators. If the NVC would like to provide additional data and information to the RVC, please submit them as separate document(s). In 2020, the World Health Organization reformed its IT systems and internet platforms for data submission and exchange in 2020 to increase security, and a new SharePoint for the European Regional Verification Commission for Measles and Rubella Elimination was created. However, due to shifting of resources and time constrains in countries and at the WHO Regional Office related to the COVID-19 pandemic response, it was not possible to prepare instructions and conduct training for NVCs and national colleagues. Therefore, we kindly request you to submit your ASU and all relevant additional documents as attachments to an e-mail to RVC Secretariat, using address [email protected]. You may also copy any of VPI technical officers cooperating with you in preparation of the ASU and verification process. Please follow up with us to confirm that we received your ASU and any other issue that may need our support or attention. This update is to be submitted to the WHO Regional Office for Europe by 1 May 2021.
    [Show full text]
  • Sir Charles Sherrington'sthe Integrative Action of the Nervous System: a Centenary Appreciation
    doi:10.1093/brain/awm022 Brain (2007), 130, 887^894 OCCASIONAL PAPER Sir Charles Sherrington’sThe integrative action of the nervous system: a centenary appreciation Robert E. Burke Formerly Chief of the Laboratory of Neural Control, National Institute of Neurological Disorders, National Institutes of Health, Bethesda, MD, USA Present address: P.O. Box 1722, El Prado, NM 87529,USA E-mail: [email protected] In 1906 Sir Charles Sherrington published The Integrative Action of the Nervous System, which was a collection of ten lectures delivered two years before at Yale University in the United States. In this monograph Sherrington summarized two decades of painstaking experimental observations and his incisive interpretation of them. It settled the then-current debate between the ‘‘Reticular Theory’’ versus ‘‘Neuron Doctrine’’ ideas about the fundamental nature of the nervous system in mammals in favor of the latter, and it changed forever the way in which subsequent generations have viewed the organization of the central nervous system. Sherrington’s magnum opus contains basic concepts and even terminology that are now second nature to every student of the subject. This brief article reviews the historical context in which the book was written, summarizes its content, and considers its impact on Neurology and Neuroscience. Keywords: Neuron Doctrine; spinal reflexes; reflex coordination; control of movement; nervous system organization Introduction The first decade of the 20th century saw two momentous The Silliman lectures events for science. The year 1905 was Albert Einstein’s Sherrington’s 1906 monograph, published simultaneously in ‘miraculous year’ during which three of his most celebrated London, New Haven and New York, was based on a series papers in theoretical physics appeared.
    [Show full text]
  • Journal of Health Monitoring | S3/2020 | EBPH-Workshop
    JUNE 2020 FEDERAL HEALTH REPORTING SPECIAL ISSUE 3 JOINT SERVICE BY RKI AND DESTATIS Journal of Health Monitoring Evidence-based Public Health for Public Health Action – Proceedings of an international workshop at the Robert Koch Institute Berlin, Germany, 14 December 2018 1 Journal of Health Monitoring Index 3 Editorial Providing actionable evidence in Public 23 Proceedings Summary of World Café Discussions Health – The 2018 international workshop on Table 3: Dissemination evidence-based public health at the Robert Koch Institute, Berlin 7 Proceedings Emerging challenges in evidence-based public health and how to address them 9 Proceedings Conceptual issues in relation to the design, implementation and evaluation of interven- tions 11 Proceedings Taking stock of existing evidence and closing evidence gaps – Reflections from the National Institute for Health and Care Excellence (NICE) 13 Proceedings Novel methods for health intervention research 15 Proceedings Systematic reviews in public health: Exploring challenges and potential solutions 17 Proceedings Evidence-based public health (EBPH) health policy advising and information of the public 19 Proceedings Experiences from the Department of Infectious Disease Epidemiology at Robert Koch Institute 21 Proceedings Summary of World Café Discussions Table 1: Assessment 22 Proceedings Summary of World Café Discussions Table 2: Evaluation JournalJournal of of Health Health Monitoring Monitoring 2018 2020 3(XXX) 5(S3) 2 Journal of Health Monitoring Evidence-based Public Health for Public Health
    [Show full text]
  • Can the New Type of Coronavirus Be Transmitted Via Food and Objects?
    www.bfr.bund.de Can the new type of coronavirus be transmitted via food and objects? Updated BfR FAQ dated 30 March 2020 After the outbreak of the respiratory tract disorder COVID-19 caused by an infection with the new type of coronavirus (SARS-CoV-2), and the subsequent epidemic in various regions of China, the virus is now also spreading in Germany and Europe. Disconcerted consumers have asked the German Federal Institute for Risk Assessment (BfR) whether the virus can also be transmitted to humans via food and imported products such as children’s toys, mo- bile telephones, articles such as door handles, tools, etc., as well as dishes and cutlery. Against this background, the BfR has summarised the most important questions and an- swers on the topic. What do we know so far about the new type of virus-related respiratory tract disorder? The new type of respiratory tract disorder COVID-19 is based on an infection with the new type of coronavirus (SARS-CoV-2), according to the current state of knowledge. Knowledge about the exact transmission methods of this coronavirus is still limited. However, the trans- mission method of other closely related coronaviruses are well known. Different types of coronavirus typically trigger conventional colds in humans. Moreover, other coronaviruses, such as the SARS and MERS coronaviruses, have occurred in the past which have led to severe respiratory tract disorders. The main target organs of the coronavirus in humans are the respiratory tract organs. The most important transmission method is a ‘droplet infection’, where coronaviruses are emitted by humans or animals into the air via droplets, and then inhaled.
    [Show full text]
  • Spread of a SARS-Cov-2 Variant Through Europe in the Summer of 2020
    Article Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 https://doi.org/10.1038/s41586-021-03677-y Emma B. Hodcroft1,2,3 ✉, Moira Zuber1, Sarah Nadeau2,4, Timothy G. Vaughan2,4, Katharine H. D. Crawford5,6,7, Christian L. Althaus3, Martina L. Reichmuth3, John E. Bowen8, Received: 25 November 2020 Alexandra C. Walls8, Davide Corti9, Jesse D. Bloom5,6,10, David Veesler8, David Mateo11, Accepted: 28 May 2021 Alberto Hernando11, Iñaki Comas12,13, Fernando González-Candelas13,14, SeqCOVID-SPAIN consortium*, Tanja Stadler2,4,92 & Richard A. Neher1,2,92 ✉ Published online: 7 June 2021 Check for updates Following its emergence in late 2019, the spread of SARS-CoV-21,2 has been tracked by phylogenetic analysis of viral genome sequences in unprecedented detail3–5. Although the virus spread globally in early 2020 before borders closed, intercontinental travel has since been greatly reduced. However, travel within Europe resumed in the summer of 2020. Here we report on a SARS-CoV-2 variant, 20E (EU1), that was identifed in Spain in early summer 2020 and subsequently spread across Europe. We fnd no evidence that this variant has increased transmissibility, but instead demonstrate how rising incidence in Spain, resumption of travel, and lack of efective screening and containment may explain the variant’s success. Despite travel restrictions, we estimate that 20E (EU1) was introduced hundreds of times to European countries by summertime travellers, which is likely to have undermined local eforts to minimize infection with SARS-CoV-2. Our results illustrate how a variant can rapidly become dominant even in the absence of a substantial transmission advantage in favourable epidemiological settings.
    [Show full text]
  • Metchnikoff and the Phagocytosis Theory
    PERSPECTIVES TIMELINE Metchnikoff and the phagocytosis theory Alfred I. Tauber Metchnikoff’s phagocytosis theory was less century. Indeed, the clonal selection theory and an explanation of host defence than a the elucidation of the molecular biology of the proposal that might account for establishing immune response count among the great and maintaining organismal ‘harmony’. By advances in biology during our own era5. tracing the phagocyte’s various functions Metchnikoff has been assigned to the wine cel- Figure 1 | Ilya Metchnikoff, at ~45 years of through phylogeny, he recognized that eating lar of history, to be pulled out on occasion and age. This figure is reproduced from REF. 14. the tadpole’s tail and killing bacteria was the celebrated as an old hero. same fundamental process: preserving the However, to cite Metchnikoff only as a con- integrity, and, in some cases, defining the tributor to early immunology distorts his sem- launched him into the turbulent waters of evo- identity of the organism. inal contributions to a much wider domain. lutionary biology. He wrote his dissertation on He recognized that the development and func- the development of invertebrate germ layers, I first encountered the work of Ilya tion of the individual organism required an for which he shared the prestigious van Baer Metchnikoff (1845–1916; FIG. 1) in Paul de understanding of physiology in an evolution- Prize with Alexander Kovalevski. By the age of Kruif’s classic, The Microbe Hunters 1.Who ary context. The crucial precept: the organism 22 years, he was appointed to the position of would not be struck by the description of this was composed of various elements, each vying docent at the new University of Odessa, where, fiery Russian championing his theory of for dominance.
    [Show full text]
  • Vaccination Recommendations for Germany Miriam Wiese-Posselt, Christine Tertilt, and Fred Zepp
    MEDICINE CONTINUING MEDICAL EDUCATION Vaccination Recommendations for Germany Miriam Wiese-Posselt, Christine Tertilt, and Fred Zepp SUMMARY accination is an effective means of preventing V infectious diseases (e1). The primary goal of vac- Background: Vaccination is an effective means of preventing cination is to protect the vaccinated person against the infectious diseases. In Germany, the Standing Vaccination disease in question (individual immunity). If a large Committee at the Robert Koch Institute (Ständige Impfkom- enough percentage of the population is vaccinated, then mission, STIKO) issues recommendations on vaccination to the spread of the pathogenic organism will be reduced prevent the occurrence and spread of infectious diseases in to such an extent that non-vaccinated persons are pro- the nation’s population. tected as well (herd immunity) (e2). Sustained vacci- Methods: Selective literature review, including consideration nation of a high percentage of the population against a of the current STIKO recommendations. pathogen for which man is the only reservoir can result Results: The annually updated vaccination calendar currently in its regional or even, in the ideal case, global elimi - includes recommendations for vaccination against diphtheria, nation (1). The total elimination of smallpox and the tetanus, pertussis, type b Haemophilus influenzae, hepatitis marked reduction of the incidence of poliomyelitis B, poliomyelitis, and pneumococci, beginning at the age of worldwide are impressive examples of the benefits of eight weeks. From the age of twelve months onward, immunization (Figure 1) (e3). children should be vaccinated against measles, mumps, rubella, varicella, and serogroup C meningococci. In later Methods childhood and adolescence, booster vaccinations are recom- In Germany, the Standing Vaccination Committee mended, in addition to the provision of any vaccina tions that (Ständige Impfkommission, STIKO) at the Robert Koch may have been missed.
    [Show full text]
  • Annual Status Update on Measles and Rubella Elimination for 2016
    ANNUAL STATUS UPDATE ON MEASLES AND RUBELLA ELIMINATION FOR 2016 Annual Status Update on Measles and Rubella Elimination for 2016 Germany 0 | P a g e ANNUAL STATUS UPDATE ON MEASLES AND RUBELLA ELIMINATION FOR 2016 This update is to be submitted to the WHO Regional Office by 15 April 2017. Please upload an electronic version of the update and a copy of page 5 signed by the NVC members to the RVC SharePoint: http://workspace.who.int/sites/EURORVC How to upload the report: 1. Make a copy of your report and any supporting documents and supplementary data in original (Microsoft Word) format. PLEASE DO NOT CONVERT THIS FILE INTO PDF FORMAT! 2. Login at “http://workspace.who.int/sites/EURORVC“ using the password provided by the WHO Secretariat to the NVC chairperson and EPI manager. You are at RVC SharePoint. 3. Click on “Country Annual Status Reports”. 4. Select and click on your country folder. 5. Open the folder for year of reporting (2016). 6. Click on “Upload” or drag the file to folder and it will be copied. 7. Click on “Browse…” or “Upload Multiple Files…” to select a single or multiple files from your PC or MAC to upload. 8. Select your file(s) and click on “OK”. 9. Double check that the files are uploaded under the Country Annual Status Reports/Your country name. Should you have any problems with access to the RVC SharePoint or uploading the report, please contact the WHO Secretariat by e-mail ([email protected]). This update report consists of three sections: Section 1: National Verification Committee (NVC) Section 2: Country measles and rubella profile Section 3: Update of general programme activities by components We would kindly ask you to follow the instructions provided in the form and enter numbers or text as required in each particular table.
    [Show full text]
  • Emil Von Behring (1854–1917) the German Bacteriologist
    Emil von Behring (1854–1917) The German bacteriologist and Nobel Prize winner Emil von Behring ranks among the most important medical scientists. Behring was born in Hansdorff, West Prussia, as the son of a teacher in 1854. He grew up in narrow circumstances among eleven brothers and sisters. His desire to study medicine could only be realized by fulfilling the obligation to work as an military doctor for a longer period of time. Between 1874 and 1878 he studied medicine at the Akademie für das militärärztliche Bildungswesen in Berlin. In 1890, after having published his paper Ueber das Zustandekommen der Diphtherie- Immunität und der Tetanus-Immunität bei Thieren, he captured his scientific breakthrough. While having worked as Robert Koch’s scientific assistant at the Berlin Hygienic Institute he had been able to show – together with his Japanese colleague Shibasaburo Kitasato (1852–1931) – via experimentation on animal that it was possible to neutralize pathogenic germs by giving „antitoxins“. Behring demonstrated that the antitoxic qualities of blood are not seated in cells, but in the cell-free serum. Antitoxins recovered of human convalenscents or laboratorty animals, prove themselves as life-saving when being applied to diseased humans. At last – due to Behring’s discovery of the body’s own immune defence and due to his development of serotherapy against diphtheria and tetanus – a remedy existed which was able to combat via antitoxin those infectious diseases which had already broken out. Having developped a serum therapy against diphtheria and tetanus Behring won the first Nobel Prize in Medicine in 1901. Six years before, in 1895, he had become professor of Hygienics within the Faculty of Medicine at the University of Marburg, a position he would hold for the rest of his life.
    [Show full text]
  • (COVID-19) Daily Situation Report of the Robert Koch Institute
    Coronavirus Disease 2019 (COVID-19) WeeklyDaily SituationSituation Report fromof the the Robert Robert Koch Koch Institute Institute CALENDAR08/01/202116/01/2021 WEEK 26/202 - UPDATED1 - CURRENT STATUS STATUS FOR GERMANY FOR GERMANY Since 6 March 2021, the Robert Koch Institute (RKI) has been publishing the English version of the COVID-19 situation reports for Germany on a weekly basis. Information on the daily epidemiological situation is available on the RKI’s online COVID-19 dashboard. In addition, the RKI’s website provides daily situation reports in German, information on vaccination data and from the intensive care registry, as well as other regularly uploaded data. [Information sources are provided at the end of this report]. The following information is provided in this situation report: Overview on the epidemiological situation, demographic distribution of cases, surveys on laboratory tests of SARS-CoV-2 in Germany, and information from additional RKI-based surveillance systems. – Changes since the last report are marked blue in the text – The current epidemiological situation in Germany As of 01 July 2021 Vaccination DIVI-Intensive care Confirmed cases 7-day incidence (7-di) monitoring register No. of districts Change to previous No. of vaccinations Total1 Active cases2 Total population with 7-di day for no. of cases reported in last 24h > 50/100,000 pop currently in ICU +892 -600 5.1 ±0 1st vaccin. + 443,036 -24 (3,729,033) [ca. 12,400] cases/100,000 pop. [0/412] 2nd vaccin. + 533,491 [590] Total no. of people No. of districts vaccinated with No. of deaths in 60-79 80+ Recovered3 Deaths with 7-di one/two vaccine ICU compared to years years > 100/100,000 pop dose/s and share of the previous day population +1,400 +63 1.9 1.4 ±0 N1: 45,817,029 (55.1%)4 + 51 (ca.
    [Show full text]